AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36354032 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil discontinuation (mycophenolate mofetil-)
Number of subjects: 230
Study 36354032 — intervention group
Group type: COMPARATOR
Intervention: Mycophenolate mofetil continuation (mycophenolate mofetil+)
Number of subjects: 230
Study 36354032 — intervention group
Group type: EXPERIMENTAL
Intervention: Local adverse events after single and double dose mRNA-1273
Number of subjects: 230
Study 36354032 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious adverse events related to vaccination
Number of subjects: 230
Study 33546844 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral nerve block (PNB) anaesthesia with ultrasound-guided popliteal sciatic and saphenous blocks using ropivacaine
Number of subjects: 150
Study 33546844 — intervention group
Group type: COMPARATOR
Intervention: Spinal anaesthesia (SA) with hyperbaric bupivacaine
Number of subjects: 150
Study 33546844 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral nerve block (PNB) anaesthesia
Number of subjects: 150
Study 33546844 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of recovery scores
Number of subjects: 150
Study 33245043 — intervention group
Group type: COMPARATOR
Intervention: Topical corticosteroids (mometasone furoate 0.1%) plus dummy narrowband ultraviolet B light
Number of subjects: 517
Study 33245043 — intervention group
Group type: COMPARATOR
Intervention: Narrowband ultraviolet B light (plus placebo topical corticosteroids)
Number of subjects: 517
Study 33245043 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination (topical corticosteroids plus narrowband ultraviolet B light)
Number of subjects: 517
Study 35176767 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning cold exposure (7:45 am)
Number of subjects: 24
Study 35176767 — intervention group
Group type: COMPARATOR
Intervention: Evening cold exposure (7:45 pm)
Number of subjects: 24
Study 32019356 — intervention group
Group type: EXPERIMENTAL
Intervention: Readmitted patients
Number of subjects: 50
Study 35426086 — intervention group
Group type: EXPERIMENTAL
Intervention: Red line incision approach
Number of subjects: 24
Study 35426086 — intervention group
Group type: COMPARATOR
Intervention: Control group (facelift incision without red line)
Number of subjects: 24
Study 34411635 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron
Number of subjects: 112
Study 34411635 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron
Number of subjects: 112
Study 36203215 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based cognitive behavioural therapy (FCBT)
Number of subjects: 0
Study 36203215 — intervention group
Group type: COMPARATOR
Intervention: Family-based psychoeducation/relaxation training (FPRT)
Number of subjects: 0
Study 35122097 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 g/day of MCTs at breakfast
Number of subjects: 40
Study 35122097 — intervention group
Group type: COMPARATOR
Intervention: 6 g/day of MCTs at dinnertime (positive control group)
Number of subjects: 40
Study 32766683 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial warnings with graphic or 'gross' images
Number of subjects: 30
Study 32766683 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial warnings with direct illustrations of warning text
Number of subjects: 30
Study 32766683 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial warnings including people, especially youth and young adults making eye contact
Number of subjects: 30
Study 32682416 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 149
Study 32682416 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 149
Study 35176037 — intervention group
Group type: EXPERIMENTAL
Intervention: CSD500 condom (n = 248)
Number of subjects: 500
Study 35176037 — intervention group
Group type: COMPARATOR
Intervention: Standard condoms (n = 252)
Number of subjects: 500
Study 33998580 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical undergraduate students
Number of subjects: 216
Study 33998580 — intervention group
Group type: COMPARATOR
Intervention: Dental undergraduate students
Number of subjects: 216
Study 34059304 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic-ceramic FDPs
Number of subjects: 96
Study 34059304 — intervention group
Group type: COMPARATOR
Intervention: Metal-ceramic FDPs
Number of subjects: 96
Study 36047294 — intervention group
Group type: EXPERIMENTAL
Intervention: J-Calc-CTO score
Number of subjects: 137
Study 36047294 — intervention group
Group type: EXPERIMENTAL
Intervention: Dense calcification (calcified-index >12)
Number of subjects: 137
Study 36047294 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcification in the center of the lumen
Number of subjects: 137
Study 36047294 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedural success rate
Number of subjects: 137
Study 36047294 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min wire crossing
Number of subjects: 137
Study 32232954 — intervention group
Group type: EXPERIMENTAL
Intervention: Family focused therapy for individuals at CHR (6 months)
Number of subjects: 0
Study 32232954 — intervention group
Group type: EXPERIMENTAL
Intervention: Family psychoeducational treatment (6 months)
Number of subjects: 0
Study 32232954 — intervention group
Group type: COMPARATOR
Intervention: Matched controls (no specific treatment mentioned)
Number of subjects: 0
Study 32295554 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 1020
Study 32295554 — intervention group
Group type: COMPARATOR
Intervention: Lying position
Number of subjects: 1020
Study 32295554 — intervention group
Group type: EXPERIMENTAL
Intervention: Early stylet removal
Number of subjects: 1020
Study 32295554 — intervention group
Group type: COMPARATOR
Intervention: Late stylet removal
Number of subjects: 1020
Study 35015247 — intervention group
Group type: EXPERIMENTAL
Intervention: Asynchronous binocular treatment using 3D movies with amblyopic eye stimulated first for 10.5 hours over <3 weeks
Number of subjects: 0
Study 35015247 — intervention group
Group type: EXPERIMENTAL
Intervention: Asynchronous binocular treatment
Number of subjects: 0
Study 35015247 — intervention group
Group type: COMPARATOR
Intervention: Patching alone
Number of subjects: 0
Study 33605356 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual eyeglasses (AVE)
Number of subjects: 44
Study 33605356 — intervention group
Group type: COMPARATOR
Intervention: Conventional behavior management techniques (control)
Number of subjects: 44
Study 35900031 — intervention group
Group type: EXPERIMENTAL
Intervention: Test nilotinib capsule (200 mg)
Number of subjects: 30
Study 35900031 — intervention group
Group type: COMPARATOR
Intervention: Reference nilotinib capsule (200 mg)
Number of subjects: 30
Study 33369651 — intervention group
Group type: EXPERIMENTAL
Intervention: Disability Rating Scale (DRS) measured during weeks 1 to 4 after TBI
Number of subjects: 200
Study 33369651 — intervention group
Group type: EXPERIMENTAL
Intervention: Disability Rating Scale (DRS)
Number of subjects: 200
Study 35413533 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring with an emphasis on acceptance training (MAT)
Number of subjects: 149
Study 35413533 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring training (MT)
Number of subjects: 149
Study 35413533 — intervention group
Group type: COMPARATOR
Intervention: Emotional regulation course (Control)
Number of subjects: 149
Study 34821563 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-guided ICBT
Number of subjects: 1169
Study 34821563 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help ICBT
Number of subjects: 1169
Study 34821563 — intervention group
Group type: COMPARATOR
Intervention: Information-only control
Number of subjects: 1169
Study 36495356 — intervention group
Group type: EXPERIMENTAL
Intervention: Active prayer (n=94)
Number of subjects: 208
Study 36495356 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive prayer (n=62)
Number of subjects: 208
Study 36495356 — intervention group
Group type: COMPARATOR
Intervention: Poem reading (control group, n=52)
Number of subjects: 208
Study 36495356 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 208
Study 32839833 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythritol air polishing
Number of subjects: 30
Study 32839833 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing with hand curettes and ultrasonic instruments
Number of subjects: 30
Study 32427792 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone sheets
Number of subjects: 0
Study 32427792 — intervention group
Group type: COMPARATOR
Intervention: Paper tape
Number of subjects: 0
Study 36454806 — intervention group
Group type: EXPERIMENTAL
Intervention: Training package for Risk Management (RM)
Number of subjects: 61
Study 35685819 — intervention group
Group type: EXPERIMENTAL
Intervention: 50000 IU vitamin D3 per week
Number of subjects: 110
Study 35685819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 33000503 — intervention group
Group type: EXPERIMENTAL
Intervention: Tralokinumab 300 mg every 2 weeks (Q2W) plus topical corticosteroids (TCS) as needed
Number of subjects: 0
Study 33000503 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus topical corticosteroids (TCS) as needed
Number of subjects: 0
Study 33000503 — intervention group
Group type: EXPERIMENTAL
Intervention: Tralokinumab Q2W plus TCS as needed
Number of subjects: 0
Study 33000503 — intervention group
Group type: EXPERIMENTAL
Intervention: Tralokinumab Q4W plus TCS as needed
Number of subjects: 0
Study 33000503 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who did not achieve IGA 0/1 and EASI 75 with tralokinumab Q2W at week 16
Number of subjects: 0
Study 32398441 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine with 1.0 ppm DEX (1.8 μg)
Number of subjects: 19
Study 32398441 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine with 2.0 ppm DEX (3.6 μg)
Number of subjects: 19
Study 32398441 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine with 1:80,000 adrenaline (22.5 μg)
Number of subjects: 19
Study 35964135 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS at the contralesional primary motor cortex (M1) along with routine medical care
Number of subjects: 140
Study 35964135 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS along with routine medical care
Number of subjects: 140
Study 33280266 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic resection
Number of subjects: 449
Study 33280266 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 449
Study 33280266 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-time employment presurgery
Number of subjects: 449
Study 33280266 — intervention group
Group type: EXPERIMENTAL
Intervention: Distant metastases at baseline
Number of subjects: 449
Study 33280266 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 449
Study 34087418 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate bolus (0.4 mg IV)
Number of subjects: 8
Study 34087418 — intervention group
Group type: EXPERIMENTAL
Intervention: Titrated glycopyrrolate (0.01 mg IV every 3 min as needed)
Number of subjects: 8
Study 34087418 — intervention group
Group type: COMPARATOR
Intervention: Control (no glycopyrrolate)
Number of subjects: 8
Study 32645143 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory memory training
Number of subjects: 0
Study 32645143 — intervention group
Group type: COMPARATOR
Intervention: Visual memory training
Number of subjects: 0
Study 35869477 — intervention group
Group type: EXPERIMENTAL
Intervention: Online collaborative learning (OCL)
Number of subjects: 124
Study 35869477 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face environment
Number of subjects: 124
Study 33971735 — intervention group
Group type: EXPERIMENTAL
Intervention: Meniscectomy or Exercise (specific intervention details not provided)
Number of subjects: 140
Study 34762233 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS at 20 mA
Number of subjects: 200
Study 34762233 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS at 30 mA
Number of subjects: 200
Study 34762233 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS at 40 mA
Number of subjects: 200
Study 33087164 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone recall with mailed self-sample HPV testing kit (n = 756)
Number of subjects: 2268
Study 33087164 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone recall with mailed self-sample HPV testing kit and patient navigation (n = 756)
Number of subjects: 2268
Study 33087164 — intervention group
Group type: COMPARATOR
Intervention: Telephone recall (enhanced usual care, n = 756)
Number of subjects: 2268
Study 32691455 — intervention group
Group type: EXPERIMENTAL
Intervention: iCAN‐DO (cocreated internet‐based stepped care)
Number of subjects: 245
Study 32691455 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 245
Study 35925736 — intervention group
Group type: EXPERIMENTAL
Intervention: Informant-reported cognitive decline
Number of subjects: 306
Study 35925736 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported cognitive decline
Number of subjects: 306
Study 35925736 — intervention group
Group type: EXPERIMENTAL
Intervention: Underestimators (68 participants)
Number of subjects: 306
Study 35925736 — intervention group
Group type: EXPERIMENTAL
Intervention: Congruent estimators (94 participants)
Number of subjects: 306
Study 35925736 — intervention group
Group type: EXPERIMENTAL
Intervention: Overestimators (144 participants)
Number of subjects: 306
Study 35925736 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive performance
Number of subjects: 306
Study 35925736 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrepancy between self- and informant-report
Number of subjects: 306
Study 33675596 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone intervention by a specific nurse 2 days before colonoscopy
Number of subjects: 162
Study 33675596 — intervention group
Group type: COMPARATOR
Intervention: Control group received education only on the day of appointment
Number of subjects: 162
Study 32660604 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious Games using Leap Motion Controller (LMC) plus conventional rehabilitation
Number of subjects: 0
Study 32660604 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 0
Study 34558386 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-minute sanitary pad test
Number of subjects: 50
Study 34558386 — intervention group
Group type: COMPARATOR
Intervention: 60-minute sanitary pad test
Number of subjects: 50
Study 32530426 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay-it-forward arm
Number of subjects: 301
Study 32530426 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay-what-you-want arm
Number of subjects: 301
Study 32530426 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care arm
Number of subjects: 301
Study 34406656 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on cannabidiol (CBD) titrated from 2.5 to 20 mg/kg/day, with potential increase to 30 mg/kg/day based on response and tolerance.
Number of subjects: 315
Study 34406656 — intervention group
Group type: EXPERIMENTAL
Intervention: Add-on cannabidiol (CBD) treatment
Number of subjects: 315
Study 33189630 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 678
Study 33189630 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (control from EVALUATE‐HF study)
Number of subjects: 678
Study 36333195 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based, theory-guided narrative intervention
Number of subjects: 0
Study 36333195 — intervention group
Group type: COMPARATOR
Intervention: Conventional genetic counseling
Number of subjects: 0
Study 32950038 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced post-donation instruction sheet (PDIS)
Number of subjects: 12935
Study 32950038 — intervention group
Group type: COMPARATOR
Intervention: Standard post-donation instruction sheet (PDIS)
Number of subjects: 12935
Study 32371518 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured Individualised Intervention and Recovery (SITAR) with an individually tailored recovery plan
Number of subjects: 200
Study 32371518 — intervention group
Group type: COMPARATOR
Intervention: Standard care (without individually tailored recovery plan)
Number of subjects: 200
Study 35891122 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS on first visit only (TN)
Number of subjects: 30
Study 35891122 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS on second visit only (NT)
Number of subjects: 30
Study 35891122 — intervention group
Group type: COMPARATOR
Intervention: Control group (NN)
Number of subjects: 30
Study 34794220 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan plus S‐1 (intravenous infusion of irinotecan 160 mg/m(2) on day 1 and oral S‐1 80‐120 mg on days 1‐10, repeated every 14 days)
Number of subjects: 46
Study 32183057 — intervention group
Group type: EXPERIMENTAL
Intervention: Total protein intake of 1 g·Kg−1·d−1 in week 2
Number of subjects: 434
Study 32183057 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intake
Number of subjects: 434
Study 32183057 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in z-scores to 4 weeks and 36 weeks’ CA
Number of subjects: 434
Study 32183057 — intervention group
Group type: EXPERIMENTAL
Intervention: Macronutrient intakes from birth to 4 weeks
Number of subjects: 434
Study 35144602 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site testing using the Xpert® CT/NG test
Number of subjects: 847
Study 35144602 — intervention group
Group type: COMPARATOR
Intervention: Off-site testing
Number of subjects: 847
Study 35144602 — intervention group
Group type: EXPERIMENTAL
Intervention: On-site testing
Number of subjects: 847
Study 34491999 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthier supermarket layout intervention (new fresh fruit and vegetable sections near entrances, frozen vegetables repositioned to entrance aisle, removal of confectionery from checkouts)
Number of subjects: 150
Study 34491999 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthier supermarket layout intervention
Number of subjects: 150
Study 34491999 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 34090551 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical manual traction
Number of subjects: 54
Study 34090551 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk stabilization maneuver
Number of subjects: 54
Study 36235676 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal graded exercise stress test (GEST)
Number of subjects: 15
Study 36235676 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise CONTROL
Number of subjects: 15
Study 34001723 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprocitentan (dual endothelin-receptor antagonist)
Number of subjects: 0
Study 34001723 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34001723 — intervention group
Group type: COMPARATOR
Intervention: Moderately dosed angiotensin-converting enzyme inhibitor
Number of subjects: 0
Study 33295528 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication by card
Number of subjects: 189
Study 33295528 — intervention group
Group type: COMPARATOR
Intervention: Verbal communication
Number of subjects: 189
Study 35311705 — intervention group
Group type: EXPERIMENTAL
Intervention: MCI (prodromal AD)
Number of subjects: 54
Study 35311705 — intervention group
Group type: COMPARATOR
Intervention: SCD
Number of subjects: 54
Study 35311705 — intervention group
Group type: COMPARATOR
Intervention: AD dementia
Number of subjects: 54
Study 33506030 — intervention group
Group type: EXPERIMENTAL
Intervention: Food safety knowledge training
Number of subjects: 430
Study 33506030 — intervention group
Group type: EXPERIMENTAL
Intervention: Food safety knowledge
Number of subjects: 430
Study 33506030 — intervention group
Group type: EXPERIMENTAL
Intervention: Food safety practices
Number of subjects: 430
Study 33506030 — intervention group
Group type: EXPERIMENTAL
Intervention: Food safety training
Number of subjects: 430
Study 35909029 — intervention group
Group type: EXPERIMENTAL
Intervention: Scenario‐Tailored Opioid Messaging Program intervention
Number of subjects: 648
Study 35909029 — intervention group
Group type: COMPARATOR
Intervention: Routine information (control)
Number of subjects: 648
Study 32171768 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarterly azithromycin distribution
Number of subjects: 60
Study 32171768 — intervention group
Group type: COMPARATOR
Intervention: Annual azithromycin distribution
Number of subjects: 60
Study 32171768 — intervention group
Group type: COMPARATOR
Intervention: Biennial azithromycin distribution
Number of subjects: 60
Study 32171768 — intervention group
Group type: COMPARATOR
Intervention: Biannual azithromycin distribution
Number of subjects: 60
Study 32171768 — intervention group
Group type: COMPARATOR
Intervention: Delayed azithromycin distribution
Number of subjects: 60
Study 34750747 — intervention group
Group type: EXPERIMENTAL
Intervention: PPV-guided fluid therapy
Number of subjects: 77
Study 34750747 — intervention group
Group type: COMPARATOR
Intervention: CVP-guided fluid therapy
Number of subjects: 77
Study 34019245 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus platinum-based chemotherapy
Number of subjects: 0
Study 34019245 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus platinum-based chemotherapy
Number of subjects: 0
Study 34019245 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab plus platinum-based chemotherapy with PD-L1 expression of at least 5%
Number of subjects: 0
Study 35007480 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 30
Study 35007480 — intervention group
Group type: COMPARATOR
Intervention: Nicotine-replacement therapies (NRT)
Number of subjects: 30
Study 33572448 — intervention group
Group type: EXPERIMENTAL
Intervention: EMOVERE program (seven two-hour sessions over a month)
Number of subjects: 88
Study 33572448 — intervention group
Group type: COMPARATOR
Intervention: Control group (received no intervention)
Number of subjects: 88
Study 32534843 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg preoperatively
Number of subjects: 111
Study 32534843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 34701521 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI) at 25 Gy in 10 fractions using 3D conformal radiotherapy (3D-CRT)
Number of subjects: 0